nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—SLC22A6—Conjugated Estrogens—osteoporosis	0.0615	0.116	CbGbCtD
Zalcitabine—CYP2C9—Estropipate—osteoporosis	0.0597	0.112	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0493	0.0927	CbGbCtD
Zalcitabine—CYP3A7—Estradiol—osteoporosis	0.0493	0.0927	CbGbCtD
Zalcitabine—CYP3A5—Estradiol—osteoporosis	0.037	0.0695	CbGbCtD
Zalcitabine—CYP3A4—Calcitriol—osteoporosis	0.0347	0.0653	CbGbCtD
Zalcitabine—CYP3A4—Estropipate—osteoporosis	0.0347	0.0653	CbGbCtD
Zalcitabine—CYP2C9—Cholecalciferol—osteoporosis	0.0308	0.0578	CbGbCtD
Zalcitabine—CYP2D6—Cholecalciferol—osteoporosis	0.0281	0.0529	CbGbCtD
Zalcitabine—CYP3A4—Ergocalciferol—osteoporosis	0.0277	0.0522	CbGbCtD
Zalcitabine—CYP2C9—Estradiol—osteoporosis	0.0248	0.0466	CbGbCtD
Zalcitabine—CYP3A4—Raloxifene—osteoporosis	0.0232	0.0435	CbGbCtD
Zalcitabine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0224	0.0421	CbGbCtD
Zalcitabine—CYP3A4—Cholecalciferol—osteoporosis	0.0179	0.0336	CbGbCtD
Zalcitabine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0164	0.0309	CbGbCtD
Zalcitabine—CYP3A4—Estradiol—osteoporosis	0.0144	0.0271	CbGbCtD
Zalcitabine—Didanosine—PNP—osteoporosis	0.0117	1	CrCbGaD
Zalcitabine—DCK—Fulvestrant—Estradiol—osteoporosis	0.00137	0.261	CbGdCrCtD
Zalcitabine—DCK—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.00129	0.245	CbGdCrCtD
Zalcitabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.00126	0.239	CbGdCrCtD
Zalcitabine—DCK—Levorphanol—Estradiol—osteoporosis	0.000908	0.173	CbGdCrCtD
Zalcitabine—DCK—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00043	0.0818	CbGdCrCtD
Zalcitabine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000261	0.00556	CbGpPWpGaD
Zalcitabine—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000257	0.00549	CbGpPWpGaD
Zalcitabine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000255	0.00544	CbGpPWpGaD
Zalcitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000253	0.0054	CbGpPWpGaD
Zalcitabine—CYP2D6—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000252	0.00537	CbGpPWpGaD
Zalcitabine—CYP2C9—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00025	0.00533	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—CYP27A1—osteoporosis	0.000214	0.00456	CbGpPWpGaD
Zalcitabine—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000211	0.00451	CbGpPWpGaD
Zalcitabine—CYP3A7—Metapathway biotransformation—CYP27A1—osteoporosis	0.000211	0.0045	CbGpPWpGaD
Zalcitabine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00021	0.00448	CbGpPWpGaD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000207	0.00441	CbGpPWpGaD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000205	0.00438	CbGpPWpGaD
Zalcitabine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000188	0.00402	CbGpPWpGaD
Zalcitabine—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000186	0.00397	CbGpPWpGaD
Zalcitabine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000183	0.0039	CbGpPWpGaD
Zalcitabine—Vertigo—Zoledronate—osteoporosis	0.000182	0.000449	CcSEcCtD
Zalcitabine—Syncope—Zoledronate—osteoporosis	0.000181	0.000448	CcSEcCtD
Zalcitabine—Leukopenia—Zoledronate—osteoporosis	0.000181	0.000447	CcSEcCtD
Zalcitabine—Oedema—Pamidronate—osteoporosis	0.000181	0.000447	CcSEcCtD
Zalcitabine—Infection—Pamidronate—osteoporosis	0.000179	0.000444	CcSEcCtD
Zalcitabine—Rhinitis—Estradiol—osteoporosis	0.000179	0.000444	CcSEcCtD
Zalcitabine—Urticaria—Calcitriol—osteoporosis	0.000179	0.000443	CcSEcCtD
Zalcitabine—Hepatitis—Estradiol—osteoporosis	0.000179	0.000442	CcSEcCtD
Zalcitabine—Palpitations—Zoledronate—osteoporosis	0.000179	0.000442	CcSEcCtD
Zalcitabine—Body temperature increased—Calcitriol—osteoporosis	0.000178	0.000441	CcSEcCtD
Zalcitabine—Abdominal pain—Calcitriol—osteoporosis	0.000178	0.000441	CcSEcCtD
Zalcitabine—Shock—Pamidronate—osteoporosis	0.000178	0.000439	CcSEcCtD
Zalcitabine—Loss of consciousness—Zoledronate—osteoporosis	0.000178	0.000439	CcSEcCtD
Zalcitabine—Pharyngitis—Estradiol—osteoporosis	0.000178	0.000439	CcSEcCtD
Zalcitabine—Hypersensitivity—Estropipate—osteoporosis	0.000177	0.000438	CcSEcCtD
Zalcitabine—Thrombocytopenia—Pamidronate—osteoporosis	0.000177	0.000437	CcSEcCtD
Zalcitabine—Vomiting—Etidronic acid—osteoporosis	0.000177	0.000437	CcSEcCtD
Zalcitabine—Cough—Zoledronate—osteoporosis	0.000176	0.000436	CcSEcCtD
Zalcitabine—Tachycardia—Pamidronate—osteoporosis	0.000176	0.000436	CcSEcCtD
Zalcitabine—Rash—Etidronic acid—osteoporosis	0.000175	0.000433	CcSEcCtD
Zalcitabine—Convulsion—Zoledronate—osteoporosis	0.000175	0.000433	CcSEcCtD
Zalcitabine—Dermatitis—Etidronic acid—osteoporosis	0.000175	0.000433	CcSEcCtD
Zalcitabine—Vertigo—Conjugated Estrogens—osteoporosis	0.000175	0.000432	CcSEcCtD
Zalcitabine—Hyperhidrosis—Pamidronate—osteoporosis	0.000175	0.000432	CcSEcCtD
Zalcitabine—Syncope—Conjugated Estrogens—osteoporosis	0.000175	0.000432	CcSEcCtD
Zalcitabine—Hypertension—Zoledronate—osteoporosis	0.000174	0.000431	CcSEcCtD
Zalcitabine—Hypersensitivity—Alendronate—osteoporosis	0.000174	0.000431	CcSEcCtD
Zalcitabine—Headache—Etidronic acid—osteoporosis	0.000174	0.00043	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000173	0.000428	CcSEcCtD
Zalcitabine—Asthenia—Estropipate—osteoporosis	0.000172	0.000426	CcSEcCtD
Zalcitabine—Visual impairment—Estradiol—osteoporosis	0.000172	0.000426	CcSEcCtD
Zalcitabine—Anorexia—Pamidronate—osteoporosis	0.000172	0.000426	CcSEcCtD
Zalcitabine—Arthralgia—Zoledronate—osteoporosis	0.000172	0.000425	CcSEcCtD
Zalcitabine—Myalgia—Zoledronate—osteoporosis	0.000172	0.000425	CcSEcCtD
Zalcitabine—Palpitations—Conjugated Estrogens—osteoporosis	0.000172	0.000425	CcSEcCtD
Zalcitabine—Insomnia—Risedronate—osteoporosis	0.000172	0.000425	CcSEcCtD
Zalcitabine—Anxiety—Zoledronate—osteoporosis	0.000171	0.000424	CcSEcCtD
Zalcitabine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000171	0.000423	CcSEcCtD
Zalcitabine—Pruritus—Estropipate—osteoporosis	0.00017	0.000421	CcSEcCtD
Zalcitabine—Discomfort—Zoledronate—osteoporosis	0.00017	0.00042	CcSEcCtD
Zalcitabine—Asthenia—Alendronate—osteoporosis	0.00017	0.00042	CcSEcCtD
Zalcitabine—Hypersensitivity—Ibandronate—osteoporosis	0.00017	0.00042	CcSEcCtD
Zalcitabine—Cough—Conjugated Estrogens—osteoporosis	0.00017	0.00042	CcSEcCtD
Zalcitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.00017	0.00362	CbGpPWpGaD
Zalcitabine—Dyspnoea—Risedronate—osteoporosis	0.000169	0.000419	CcSEcCtD
Zalcitabine—Convulsion—Conjugated Estrogens—osteoporosis	0.000169	0.000417	CcSEcCtD
Zalcitabine—Dry mouth—Zoledronate—osteoporosis	0.000168	0.000416	CcSEcCtD
Zalcitabine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000168	0.000415	CcSEcCtD
Zalcitabine—Pruritus—Alendronate—osteoporosis	0.000167	0.000414	CcSEcCtD
Zalcitabine—CYP3A43—Biological oxidations—POMC—osteoporosis	0.000167	0.00358	CbGpPWpGaD
Zalcitabine—Dyspepsia—Risedronate—osteoporosis	0.000167	0.000413	CcSEcCtD
Zalcitabine—Eye disorder—Estradiol—osteoporosis	0.000167	0.000413	CcSEcCtD
Zalcitabine—Tinnitus—Estradiol—osteoporosis	0.000167	0.000413	CcSEcCtD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000167	0.00356	CbGpPWpGaD
Zalcitabine—Confusional state—Zoledronate—osteoporosis	0.000166	0.000411	CcSEcCtD
Zalcitabine—Hypersensitivity—Calcitriol—osteoporosis	0.000166	0.000411	CcSEcCtD
Zalcitabine—Flushing—Estradiol—osteoporosis	0.000166	0.000411	CcSEcCtD
Zalcitabine—Myalgia—Conjugated Estrogens—osteoporosis	0.000166	0.00041	CcSEcCtD
Zalcitabine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000166	0.00041	CcSEcCtD
Zalcitabine—Asthenia—Ibandronate—osteoporosis	0.000165	0.000409	CcSEcCtD
Zalcitabine—Anxiety—Conjugated Estrogens—osteoporosis	0.000165	0.000408	CcSEcCtD
Zalcitabine—Oedema—Zoledronate—osteoporosis	0.000165	0.000408	CcSEcCtD
Zalcitabine—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000165	0.00351	CbGpPWpGaD
Zalcitabine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000165	0.000407	CcSEcCtD
Zalcitabine—Diarrhoea—Estropipate—osteoporosis	0.000164	0.000407	CcSEcCtD
Zalcitabine—Infection—Zoledronate—osteoporosis	0.000164	0.000405	CcSEcCtD
Zalcitabine—Fatigue—Risedronate—osteoporosis	0.000164	0.000405	CcSEcCtD
Zalcitabine—Insomnia—Pamidronate—osteoporosis	0.000163	0.000404	CcSEcCtD
Zalcitabine—Pruritus—Ibandronate—osteoporosis	0.000163	0.000403	CcSEcCtD
Zalcitabine—Pain—Risedronate—osteoporosis	0.000162	0.000402	CcSEcCtD
Zalcitabine—Shock—Zoledronate—osteoporosis	0.000162	0.000401	CcSEcCtD
Zalcitabine—Diarrhoea—Alendronate—osteoporosis	0.000162	0.000401	CcSEcCtD
Zalcitabine—Asthenia—Calcitriol—osteoporosis	0.000162	0.0004	CcSEcCtD
Zalcitabine—Thrombocytopenia—Zoledronate—osteoporosis	0.000161	0.000399	CcSEcCtD
Zalcitabine—Dyspnoea—Pamidronate—osteoporosis	0.000161	0.000398	CcSEcCtD
Zalcitabine—Tachycardia—Zoledronate—osteoporosis	0.000161	0.000398	CcSEcCtD
Zalcitabine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000161	0.000397	CcSEcCtD
Zalcitabine—Chills—Estradiol—osteoporosis	0.000161	0.000397	CcSEcCtD
Zalcitabine—Somnolence—Pamidronate—osteoporosis	0.000161	0.000397	CcSEcCtD
Zalcitabine—DCK—Metabolism—PKM—osteoporosis	0.00016	0.00342	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—FDPS—osteoporosis	0.00016	0.00342	CbGpPWpGaD
Zalcitabine—Skin disorder—Zoledronate—osteoporosis	0.00016	0.000396	CcSEcCtD
Zalcitabine—Pruritus—Calcitriol—osteoporosis	0.00016	0.000395	CcSEcCtD
Zalcitabine—Hyperhidrosis—Zoledronate—osteoporosis	0.000159	0.000394	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000159	0.000394	CcSEcCtD
Zalcitabine—Diarrhoea—Raloxifene—osteoporosis	0.000159	0.000394	CcSEcCtD
Zalcitabine—Dyspepsia—Pamidronate—osteoporosis	0.000159	0.000393	CcSEcCtD
Zalcitabine—Dizziness—Estropipate—osteoporosis	0.000159	0.000393	CcSEcCtD
Zalcitabine—Oedema—Conjugated Estrogens—osteoporosis	0.000159	0.000393	CcSEcCtD
Zalcitabine—Alopecia—Estradiol—osteoporosis	0.000158	0.000391	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—PKM—osteoporosis	0.000158	0.00337	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—FDPS—osteoporosis	0.000158	0.00337	CbGpPWpGaD
Zalcitabine—Infection—Conjugated Estrogens—osteoporosis	0.000158	0.00039	CcSEcCtD
Zalcitabine—Diarrhoea—Ibandronate—osteoporosis	0.000158	0.00039	CcSEcCtD
Zalcitabine—Anorexia—Zoledronate—osteoporosis	0.000157	0.000389	CcSEcCtD
Zalcitabine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000157	0.00335	CbGpPWpGaD
Zalcitabine—Decreased appetite—Pamidronate—osteoporosis	0.000157	0.000388	CcSEcCtD
Zalcitabine—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000157	0.00334	CbGpPWpGaD
Zalcitabine—Dizziness—Alendronate—osteoporosis	0.000157	0.000387	CcSEcCtD
Zalcitabine—Shock—Conjugated Estrogens—osteoporosis	0.000156	0.000386	CcSEcCtD
Zalcitabine—Fatigue—Pamidronate—osteoporosis	0.000156	0.000385	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Risedronate—osteoporosis	0.000155	0.000384	CcSEcCtD
Zalcitabine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000155	0.000383	CcSEcCtD
Zalcitabine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000155	0.000383	CcSEcCtD
Zalcitabine—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	0.000154	0.0033	CbGpPWpGaD
Zalcitabine—Pain—Pamidronate—osteoporosis	0.000154	0.000382	CcSEcCtD
Zalcitabine—Diarrhoea—Calcitriol—osteoporosis	0.000154	0.000382	CcSEcCtD
Zalcitabine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000154	0.000381	CcSEcCtD
Zalcitabine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000154	0.000381	CcSEcCtD
Zalcitabine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000154	0.000381	CcSEcCtD
Zalcitabine—Dizziness—Raloxifene—osteoporosis	0.000154	0.000381	CcSEcCtD
Zalcitabine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000154	0.00038	CcSEcCtD
Zalcitabine—Flatulence—Estradiol—osteoporosis	0.000153	0.00038	CcSEcCtD
Zalcitabine—Tension—Estradiol—osteoporosis	0.000153	0.000378	CcSEcCtD
Zalcitabine—Vomiting—Estropipate—osteoporosis	0.000153	0.000378	CcSEcCtD
Zalcitabine—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000153	0.00326	CbGpPWpGaD
Zalcitabine—Dysgeusia—Estradiol—osteoporosis	0.000153	0.000377	CcSEcCtD
Zalcitabine—Dizziness—Ibandronate—osteoporosis	0.000152	0.000377	CcSEcCtD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000152	0.00325	CbGpPWpGaD
Zalcitabine—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	0.000152	0.00325	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PGLS—osteoporosis	0.000152	0.00325	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GPD2—osteoporosis	0.000152	0.00325	CbGpPWpGaD
Zalcitabine—Rash—Estropipate—osteoporosis	0.000152	0.000375	CcSEcCtD
Zalcitabine—Dermatitis—Estropipate—osteoporosis	0.000151	0.000374	CcSEcCtD
Zalcitabine—Anorexia—Conjugated Estrogens—osteoporosis	0.000151	0.000374	CcSEcCtD
Zalcitabine—Nervousness—Estradiol—osteoporosis	0.000151	0.000374	CcSEcCtD
Zalcitabine—Urticaria—Risedronate—osteoporosis	0.000151	0.000373	CcSEcCtD
Zalcitabine—Back pain—Estradiol—osteoporosis	0.000151	0.000373	CcSEcCtD
Zalcitabine—Headache—Estropipate—osteoporosis	0.000151	0.000372	CcSEcCtD
Zalcitabine—Vomiting—Alendronate—osteoporosis	0.000151	0.000372	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00015	0.000372	CcSEcCtD
Zalcitabine—Abdominal pain—Risedronate—osteoporosis	0.00015	0.000371	CcSEcCtD
Zalcitabine—Body temperature increased—Risedronate—osteoporosis	0.00015	0.000371	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—PGLS—osteoporosis	0.00015	0.0032	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GPD2—osteoporosis	0.00015	0.0032	CbGpPWpGaD
Zalcitabine—Muscle spasms—Estradiol—osteoporosis	0.00015	0.00037	CcSEcCtD
Zalcitabine—Rash—Alendronate—osteoporosis	0.000149	0.000369	CcSEcCtD
Zalcitabine—Insomnia—Zoledronate—osteoporosis	0.000149	0.000369	CcSEcCtD
Zalcitabine—Dermatitis—Alendronate—osteoporosis	0.000149	0.000369	CcSEcCtD
Zalcitabine—Feeling abnormal—Pamidronate—osteoporosis	0.000149	0.000368	CcSEcCtD
Zalcitabine—Headache—Alendronate—osteoporosis	0.000148	0.000367	CcSEcCtD
Zalcitabine—Vomiting—Raloxifene—osteoporosis	0.000148	0.000366	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000148	0.000365	CcSEcCtD
Zalcitabine—Dyspnoea—Zoledronate—osteoporosis	0.000147	0.000364	CcSEcCtD
Zalcitabine—Rash—Raloxifene—osteoporosis	0.000147	0.000363	CcSEcCtD
Zalcitabine—Dermatitis—Raloxifene—osteoporosis	0.000147	0.000363	CcSEcCtD
Zalcitabine—Somnolence—Zoledronate—osteoporosis	0.000147	0.000363	CcSEcCtD
Zalcitabine—Vomiting—Ibandronate—osteoporosis	0.000147	0.000362	CcSEcCtD
Zalcitabine—Tremor—Estradiol—osteoporosis	0.000146	0.000361	CcSEcCtD
Zalcitabine—Headache—Raloxifene—osteoporosis	0.000146	0.000361	CcSEcCtD
Zalcitabine—Rash—Ibandronate—osteoporosis	0.000145	0.000359	CcSEcCtD
Zalcitabine—Dermatitis—Ibandronate—osteoporosis	0.000145	0.000359	CcSEcCtD
Zalcitabine—Dyspepsia—Zoledronate—osteoporosis	0.000145	0.000359	CcSEcCtD
Zalcitabine—SLC29A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000145	0.00309	CbGpPWpGaD
Zalcitabine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000145	0.000358	CcSEcCtD
Zalcitabine—Ill-defined disorder—Estradiol—osteoporosis	0.000145	0.000357	CcSEcCtD
Zalcitabine—Headache—Ibandronate—osteoporosis	0.000144	0.000357	CcSEcCtD
Zalcitabine—Insomnia—Conjugated Estrogens—osteoporosis	0.000144	0.000355	CcSEcCtD
Zalcitabine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000144	0.000355	CcSEcCtD
Zalcitabine—Vomiting—Calcitriol—osteoporosis	0.000143	0.000355	CcSEcCtD
Zalcitabine—Decreased appetite—Zoledronate—osteoporosis	0.000143	0.000355	CcSEcCtD
Zalcitabine—Agitation—Estradiol—osteoporosis	0.000143	0.000354	CcSEcCtD
Zalcitabine—Body temperature increased—Pamidronate—osteoporosis	0.000143	0.000353	CcSEcCtD
Zalcitabine—Abdominal pain—Pamidronate—osteoporosis	0.000143	0.000353	CcSEcCtD
Zalcitabine—Rash—Calcitriol—osteoporosis	0.000142	0.000352	CcSEcCtD
Zalcitabine—Fatigue—Zoledronate—osteoporosis	0.000142	0.000352	CcSEcCtD
Zalcitabine—Dermatitis—Calcitriol—osteoporosis	0.000142	0.000351	CcSEcCtD
Zalcitabine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000142	0.00035	CcSEcCtD
Zalcitabine—Headache—Calcitriol—osteoporosis	0.000141	0.00035	CcSEcCtD
Zalcitabine—Somnolence—Conjugated Estrogens—osteoporosis	0.000141	0.000349	CcSEcCtD
Zalcitabine—Pain—Zoledronate—osteoporosis	0.000141	0.000349	CcSEcCtD
Zalcitabine—Malaise—Estradiol—osteoporosis	0.00014	0.000347	CcSEcCtD
Zalcitabine—Hypersensitivity—Risedronate—osteoporosis	0.00014	0.000346	CcSEcCtD
Zalcitabine—Vertigo—Estradiol—osteoporosis	0.00014	0.000346	CcSEcCtD
Zalcitabine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00014	0.000346	CcSEcCtD
Zalcitabine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00014	0.000346	CcSEcCtD
Zalcitabine—Syncope—Estradiol—osteoporosis	0.00014	0.000345	CcSEcCtD
Zalcitabine—DCK—Metabolism—PNP—osteoporosis	0.000139	0.00297	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ATIC—osteoporosis	0.000139	0.00297	CbGpPWpGaD
Zalcitabine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000138	0.000341	CcSEcCtD
Zalcitabine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000138	0.000341	CcSEcCtD
Zalcitabine—Palpitations—Estradiol—osteoporosis	0.000138	0.00034	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—ATIC—osteoporosis	0.000137	0.00292	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PNP—osteoporosis	0.000137	0.00292	CbGpPWpGaD
Zalcitabine—Fatigue—Conjugated Estrogens—osteoporosis	0.000137	0.000339	CcSEcCtD
Zalcitabine—Loss of consciousness—Estradiol—osteoporosis	0.000137	0.000339	CcSEcCtD
Zalcitabine—Asthenia—Risedronate—osteoporosis	0.000136	0.000337	CcSEcCtD
Zalcitabine—Feeling abnormal—Zoledronate—osteoporosis	0.000136	0.000336	CcSEcCtD
Zalcitabine—Cough—Estradiol—osteoporosis	0.000136	0.000336	CcSEcCtD
Zalcitabine—Pain—Conjugated Estrogens—osteoporosis	0.000136	0.000336	CcSEcCtD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000135	0.00289	CbGpPWpGaD
Zalcitabine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000135	0.000334	CcSEcCtD
Zalcitabine—Hypertension—Estradiol—osteoporosis	0.000134	0.000333	CcSEcCtD
Zalcitabine—Pruritus—Risedronate—osteoporosis	0.000134	0.000332	CcSEcCtD
Zalcitabine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000134	0.00286	CbGpPWpGaD
Zalcitabine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000133	0.00033	CcSEcCtD
Zalcitabine—Hypersensitivity—Pamidronate—osteoporosis	0.000133	0.000329	CcSEcCtD
Zalcitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000133	0.00284	CbGpPWpGaD
Zalcitabine—Myalgia—Estradiol—osteoporosis	0.000133	0.000328	CcSEcCtD
Zalcitabine—Arthralgia—Estradiol—osteoporosis	0.000133	0.000328	CcSEcCtD
Zalcitabine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000132	0.00282	CbGpPWpGaD
Zalcitabine—Anxiety—Estradiol—osteoporosis	0.000132	0.000327	CcSEcCtD
Zalcitabine—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000131	0.0028	CbGpPWpGaD
Zalcitabine—Urticaria—Zoledronate—osteoporosis	0.000131	0.000324	CcSEcCtD
Zalcitabine—Discomfort—Estradiol—osteoporosis	0.000131	0.000324	CcSEcCtD
Zalcitabine—Body temperature increased—Zoledronate—osteoporosis	0.00013	0.000322	CcSEcCtD
Zalcitabine—Abdominal pain—Zoledronate—osteoporosis	0.00013	0.000322	CcSEcCtD
Zalcitabine—Diarrhoea—Risedronate—osteoporosis	0.00013	0.000321	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00013	0.000321	CcSEcCtD
Zalcitabine—Dry mouth—Estradiol—osteoporosis	0.00013	0.000321	CcSEcCtD
Zalcitabine—Asthenia—Pamidronate—osteoporosis	0.00013	0.00032	CcSEcCtD
Zalcitabine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000129	0.000319	CcSEcCtD
Zalcitabine—Confusional state—Estradiol—osteoporosis	0.000128	0.000317	CcSEcCtD
Zalcitabine—Pruritus—Pamidronate—osteoporosis	0.000128	0.000316	CcSEcCtD
Zalcitabine—Oedema—Estradiol—osteoporosis	0.000127	0.000314	CcSEcCtD
Zalcitabine—CYP3A7—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000127	0.00271	CbGpPWpGaD
Zalcitabine—Infection—Estradiol—osteoporosis	0.000126	0.000312	CcSEcCtD
Zalcitabine—Urticaria—Conjugated Estrogens—osteoporosis	0.000126	0.000312	CcSEcCtD
Zalcitabine—Dizziness—Risedronate—osteoporosis	0.000126	0.000311	CcSEcCtD
Zalcitabine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000126	0.00031	CcSEcCtD
Zalcitabine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000126	0.00031	CcSEcCtD
Zalcitabine—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	0.000125	0.00267	CbGpPWpGaD
Zalcitabine—Shock—Estradiol—osteoporosis	0.000125	0.000309	CcSEcCtD
Zalcitabine—Tachycardia—Estradiol—osteoporosis	0.000124	0.000307	CcSEcCtD
Zalcitabine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000124	0.000306	CcSEcCtD
Zalcitabine—Diarrhoea—Pamidronate—osteoporosis	0.000124	0.000306	CcSEcCtD
Zalcitabine—Skin disorder—Estradiol—osteoporosis	0.000123	0.000305	CcSEcCtD
Zalcitabine—Hyperhidrosis—Estradiol—osteoporosis	0.000123	0.000304	CcSEcCtD
Zalcitabine—Rash—Ethinyl Estradiol—osteoporosis	0.000123	0.000304	CcSEcCtD
Zalcitabine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000123	0.000303	CcSEcCtD
Zalcitabine—Headache—Ethinyl Estradiol—osteoporosis	0.000122	0.000302	CcSEcCtD
Zalcitabine—Hypersensitivity—Zoledronate—osteoporosis	0.000122	0.000301	CcSEcCtD
Zalcitabine—Vomiting—Risedronate—osteoporosis	0.000121	0.000299	CcSEcCtD
Zalcitabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000121	0.00257	CbGpPWpGaD
Zalcitabine—Rash—Risedronate—osteoporosis	0.00012	0.000296	CcSEcCtD
Zalcitabine—Dermatitis—Risedronate—osteoporosis	0.00012	0.000296	CcSEcCtD
Zalcitabine—Dizziness—Pamidronate—osteoporosis	0.000119	0.000295	CcSEcCtD
Zalcitabine—Headache—Risedronate—osteoporosis	0.000119	0.000294	CcSEcCtD
Zalcitabine—Asthenia—Zoledronate—osteoporosis	0.000118	0.000293	CcSEcCtD
Zalcitabine—DCK—Metabolism—OXCT1—osteoporosis	0.000118	0.00252	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CA2—osteoporosis	0.000118	0.00252	CbGpPWpGaD
Zalcitabine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000117	0.000289	CcSEcCtD
Zalcitabine—Pruritus—Zoledronate—osteoporosis	0.000117	0.000289	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—OXCT1—osteoporosis	0.000116	0.00249	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CA2—osteoporosis	0.000116	0.00249	CbGpPWpGaD
Zalcitabine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000116	0.000286	CcSEcCtD
Zalcitabine—DCK—Metabolism—MGLL—osteoporosis	0.000115	0.00246	CbGpPWpGaD
Zalcitabine—Insomnia—Estradiol—osteoporosis	0.000115	0.000284	CcSEcCtD
Zalcitabine—Vomiting—Pamidronate—osteoporosis	0.000115	0.000284	CcSEcCtD
Zalcitabine—Asthenia—Conjugated Estrogens—osteoporosis	0.000114	0.000282	CcSEcCtD
Zalcitabine—Rash—Pamidronate—osteoporosis	0.000114	0.000282	CcSEcCtD
Zalcitabine—Dermatitis—Pamidronate—osteoporosis	0.000114	0.000281	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—MGLL—osteoporosis	0.000113	0.00242	CbGpPWpGaD
Zalcitabine—Dyspnoea—Estradiol—osteoporosis	0.000113	0.00028	CcSEcCtD
Zalcitabine—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000113	0.00242	CbGpPWpGaD
Zalcitabine—Headache—Pamidronate—osteoporosis	0.000113	0.00028	CcSEcCtD
Zalcitabine—Somnolence—Estradiol—osteoporosis	0.000113	0.000279	CcSEcCtD
Zalcitabine—Diarrhoea—Zoledronate—osteoporosis	0.000113	0.000279	CcSEcCtD
Zalcitabine—Pruritus—Conjugated Estrogens—osteoporosis	0.000112	0.000278	CcSEcCtD
Zalcitabine—CYP3A7—Biological oxidations—CYP19A1—osteoporosis	0.000112	0.0024	CbGpPWpGaD
Zalcitabine—Dyspepsia—Estradiol—osteoporosis	0.000112	0.000277	CcSEcCtD
Zalcitabine—CYP3A7—Metapathway biotransformation—CYP19A1—osteoporosis	0.000111	0.00236	CbGpPWpGaD
Zalcitabine—Decreased appetite—Estradiol—osteoporosis	0.00011	0.000273	CcSEcCtD
Zalcitabine—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	0.00011	0.00234	CbGpPWpGaD
Zalcitabine—Fatigue—Estradiol—osteoporosis	0.00011	0.000271	CcSEcCtD
Zalcitabine—Dizziness—Zoledronate—osteoporosis	0.000109	0.00027	CcSEcCtD
Zalcitabine—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.000109	0.00232	CbGpPWpGaD
Zalcitabine—Pain—Estradiol—osteoporosis	0.000109	0.000269	CcSEcCtD
Zalcitabine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000109	0.000269	CcSEcCtD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000109	0.00232	CbGpPWpGaD
Zalcitabine—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000108	0.00231	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	0.000108	0.00231	CbGpPWpGaD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000108	0.0023	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000107	0.00229	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000107	0.00228	CbGpPWpGaD
Zalcitabine—Dizziness—Conjugated Estrogens—osteoporosis	0.000105	0.00026	CcSEcCtD
Zalcitabine—Vomiting—Zoledronate—osteoporosis	0.000105	0.000259	CcSEcCtD
Zalcitabine—Feeling abnormal—Estradiol—osteoporosis	0.000105	0.000259	CcSEcCtD
Zalcitabine—Rash—Zoledronate—osteoporosis	0.000104	0.000257	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Estradiol—osteoporosis	0.000104	0.000257	CcSEcCtD
Zalcitabine—Dermatitis—Zoledronate—osteoporosis	0.000104	0.000257	CcSEcCtD
Zalcitabine—Headache—Zoledronate—osteoporosis	0.000103	0.000256	CcSEcCtD
Zalcitabine—Vomiting—Conjugated Estrogens—osteoporosis	0.000101	0.00025	CcSEcCtD
Zalcitabine—Urticaria—Estradiol—osteoporosis	0.000101	0.00025	CcSEcCtD
Zalcitabine—Body temperature increased—Estradiol—osteoporosis	0.0001	0.000248	CcSEcCtD
Zalcitabine—Abdominal pain—Estradiol—osteoporosis	0.0001	0.000248	CcSEcCtD
Zalcitabine—SLC29A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.0001	0.00214	CbGpPWpGaD
Zalcitabine—Rash—Conjugated Estrogens—osteoporosis	0.0001	0.000248	CcSEcCtD
Zalcitabine—Dermatitis—Conjugated Estrogens—osteoporosis	0.0001	0.000247	CcSEcCtD
Zalcitabine—Headache—Conjugated Estrogens—osteoporosis	9.95e-05	0.000246	CcSEcCtD
Zalcitabine—DCK—Metabolism—IDH2—osteoporosis	9.8e-05	0.00209	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—IDH2—osteoporosis	9.65e-05	0.00206	CbGpPWpGaD
Zalcitabine—Hypersensitivity—Estradiol—osteoporosis	9.36e-05	0.000232	CcSEcCtD
Zalcitabine—DCK—Metabolism—CYP27A1—osteoporosis	9.21e-05	0.00197	CbGpPWpGaD
Zalcitabine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	9.18e-05	0.00196	CbGpPWpGaD
Zalcitabine—Asthenia—Estradiol—osteoporosis	9.12e-05	0.000226	CcSEcCtD
Zalcitabine—CYP3A43—Metabolism—CYP27A1—osteoporosis	9.07e-05	0.00194	CbGpPWpGaD
Zalcitabine—Pruritus—Estradiol—osteoporosis	8.99e-05	0.000222	CcSEcCtD
Zalcitabine—DCK—Metabolism—ACP5—osteoporosis	8.96e-05	0.00191	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ACP5—osteoporosis	8.82e-05	0.00188	CbGpPWpGaD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.76e-05	0.00187	CbGpPWpGaD
Zalcitabine—Diarrhoea—Estradiol—osteoporosis	8.7e-05	0.000215	CcSEcCtD
Zalcitabine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.64e-05	0.00185	CbGpPWpGaD
Zalcitabine—Dizziness—Estradiol—osteoporosis	8.41e-05	0.000208	CcSEcCtD
Zalcitabine—DCK—Metabolism—TPI1—osteoporosis	8.33e-05	0.00178	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—TPI1—osteoporosis	8.2e-05	0.00175	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	8.11e-05	0.00173	CbGpPWpGaD
Zalcitabine—Vomiting—Estradiol—osteoporosis	8.08e-05	0.0002	CcSEcCtD
Zalcitabine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.05e-05	0.00172	CbGpPWpGaD
Zalcitabine—Rash—Estradiol—osteoporosis	8.01e-05	0.000198	CcSEcCtD
Zalcitabine—Dermatitis—Estradiol—osteoporosis	8.01e-05	0.000198	CcSEcCtD
Zalcitabine—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	8e-05	0.00171	CbGpPWpGaD
Zalcitabine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.98e-05	0.0017	CbGpPWpGaD
Zalcitabine—Headache—Estradiol—osteoporosis	7.96e-05	0.000197	CcSEcCtD
Zalcitabine—DCK—Metabolism—P4HB—osteoporosis	7.83e-05	0.00167	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—P4HB—osteoporosis	7.71e-05	0.00165	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GAPDH—osteoporosis	7.69e-05	0.00164	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GAPDH—osteoporosis	7.57e-05	0.00162	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—RAP1A—osteoporosis	7.49e-05	0.0016	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—RAP1A—osteoporosis	7.37e-05	0.00157	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.28e-05	0.00155	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	7.18e-05	0.00153	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.1e-05	0.00152	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	7.08e-05	0.00151	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	6.9e-05	0.00147	CbGpPWpGaD
Zalcitabine—CYP3A7—Biological oxidations—POMC—osteoporosis	6.75e-05	0.00144	CbGpPWpGaD
Zalcitabine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.53e-05	0.00139	CbGpPWpGaD
Zalcitabine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.47e-05	0.00138	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—FDPS—osteoporosis	6.36e-05	0.00136	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PKM—osteoporosis	6.36e-05	0.00136	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ENO1—osteoporosis	6.05e-05	0.00129	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GPD2—osteoporosis	6.03e-05	0.00129	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PGLS—osteoporosis	6.03e-05	0.00129	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PSMA2—osteoporosis	5.96e-05	0.00127	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—PSMA5—osteoporosis	5.96e-05	0.00127	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ENO1—osteoporosis	5.96e-05	0.00127	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PSMA2—osteoporosis	5.87e-05	0.00125	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—PSMA5—osteoporosis	5.87e-05	0.00125	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	5.77e-05	0.00123	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	5.72e-05	0.00122	CbGpPWpGaD
Zalcitabine—SLC22A7—Transmembrane transport of small molecules—ADCY5—osteoporosis	5.72e-05	0.00122	CbGpPWpGaD
Zalcitabine—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	5.69e-05	0.00121	CbGpPWpGaD
Zalcitabine—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	5.64e-05	0.0012	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PNP—osteoporosis	5.52e-05	0.00118	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ATIC—osteoporosis	5.52e-05	0.00118	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.37e-05	0.00115	CbGpPWpGaD
Zalcitabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.26e-05	0.00112	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.23e-05	0.00112	CbGpPWpGaD
Zalcitabine—CYP3A5—Biological oxidations—POMC—osteoporosis	4.88e-05	0.00104	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—CYP19A1—osteoporosis	4.84e-05	0.00103	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—CYP19A1—osteoporosis	4.77e-05	0.00102	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CA2—osteoporosis	4.69e-05	0.001	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—OXCT1—osteoporosis	4.69e-05	0.001	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PKM—osteoporosis	4.6e-05	0.000982	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—FDPS—osteoporosis	4.6e-05	0.000982	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MGLL—osteoporosis	4.57e-05	0.000976	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GPD2—osteoporosis	4.36e-05	0.000931	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PGLS—osteoporosis	4.36e-05	0.000931	CbGpPWpGaD
Zalcitabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.27e-05	0.000911	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.18e-05	0.000893	CbGpPWpGaD
Zalcitabine—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	4.01e-05	0.000856	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PNP—osteoporosis	3.99e-05	0.000851	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ATIC—osteoporosis	3.99e-05	0.000851	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—ADCY5—osteoporosis	3.95e-05	0.000844	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—GPX1—osteoporosis	3.94e-05	0.000841	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—ADCY5—osteoporosis	3.89e-05	0.000831	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—IDH2—osteoporosis	3.89e-05	0.00083	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—GPX1—osteoporosis	3.88e-05	0.000828	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.77e-05	0.000805	CbGpPWpGaD
Zalcitabine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.72e-05	0.000794	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP27A1—osteoporosis	3.65e-05	0.00078	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—MTHFR—osteoporosis	3.64e-05	0.000776	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—MTHFR—osteoporosis	3.58e-05	0.000765	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.55e-05	0.000759	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ACP5—osteoporosis	3.55e-05	0.000759	CbGpPWpGaD
Zalcitabine—CYP2D6—Biological oxidations—POMC—osteoporosis	3.47e-05	0.00074	CbGpPWpGaD
Zalcitabine—CYP2C9—Biological oxidations—POMC—osteoporosis	3.44e-05	0.000734	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CA2—osteoporosis	3.39e-05	0.000724	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—OXCT1—osteoporosis	3.39e-05	0.000724	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—TPI1—osteoporosis	3.3e-05	0.000705	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MGLL—osteoporosis	3.3e-05	0.000705	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PKM—osteoporosis	3.27e-05	0.000698	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—FDPS—osteoporosis	3.27e-05	0.000698	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—FDPS—osteoporosis	3.24e-05	0.000692	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PKM—osteoporosis	3.24e-05	0.000692	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—P4HB—osteoporosis	3.11e-05	0.000663	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PGLS—osteoporosis	3.1e-05	0.000662	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GPD2—osteoporosis	3.1e-05	0.000662	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GPD2—osteoporosis	3.07e-05	0.000656	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PGLS—osteoporosis	3.07e-05	0.000656	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GAPDH—osteoporosis	3.05e-05	0.000651	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—RAP1A—osteoporosis	2.97e-05	0.000634	CbGpPWpGaD
Zalcitabine—DCK—Metabolism—POMC—osteoporosis	2.91e-05	0.000621	CbGpPWpGaD
Zalcitabine—CYP3A43—Metabolism—POMC—osteoporosis	2.86e-05	0.000611	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ATIC—osteoporosis	2.84e-05	0.000605	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PNP—osteoporosis	2.84e-05	0.000605	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ATIC—osteoporosis	2.81e-05	0.0006	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PNP—osteoporosis	2.81e-05	0.0006	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—IDH2—osteoporosis	2.81e-05	0.0006	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.64e-05	0.000564	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ACP5—osteoporosis	2.57e-05	0.000549	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—OXCT1—osteoporosis	2.41e-05	0.000515	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CA2—osteoporosis	2.41e-05	0.000515	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ENO1—osteoporosis	2.4e-05	0.000513	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—OXCT1—osteoporosis	2.39e-05	0.00051	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CA2—osteoporosis	2.39e-05	0.00051	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—TPI1—osteoporosis	2.39e-05	0.00051	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PSMA5—osteoporosis	2.37e-05	0.000505	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—PSMA2—osteoporosis	2.37e-05	0.000505	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MGLL—osteoporosis	2.35e-05	0.000502	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MGLL—osteoporosis	2.33e-05	0.000497	CbGpPWpGaD
Zalcitabine—CYP3A4—Biological oxidations—POMC—osteoporosis	2.27e-05	0.000484	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—P4HB—osteoporosis	2.25e-05	0.000479	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GAPDH—osteoporosis	2.2e-05	0.000471	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.2e-05	0.000469	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—RAP1A—osteoporosis	2.15e-05	0.000458	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PKM—osteoporosis	2.14e-05	0.000456	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—FDPS—osteoporosis	2.14e-05	0.000456	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GPD2—osteoporosis	2.03e-05	0.000433	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PGLS—osteoporosis	2.03e-05	0.000433	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—IDH2—osteoporosis	2e-05	0.000426	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—IDH2—osteoporosis	1.98e-05	0.000423	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.92e-05	0.00041	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.88e-05	0.000401	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.86e-05	0.000397	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ATIC—osteoporosis	1.85e-05	0.000396	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PNP—osteoporosis	1.85e-05	0.000396	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ACP5—osteoporosis	1.83e-05	0.00039	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ACP5—osteoporosis	1.81e-05	0.000387	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.79e-05	0.000382	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ENO1—osteoporosis	1.74e-05	0.000371	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PSMA2—osteoporosis	1.71e-05	0.000365	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—PSMA5—osteoporosis	1.71e-05	0.000365	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—TPI1—osteoporosis	1.7e-05	0.000363	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—TPI1—osteoporosis	1.68e-05	0.000359	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—P4HB—osteoporosis	1.6e-05	0.000341	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—P4HB—osteoporosis	1.58e-05	0.000338	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CA2—osteoporosis	1.58e-05	0.000336	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.58e-05	0.000336	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—ADCY5—osteoporosis	1.57e-05	0.000335	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GAPDH—osteoporosis	1.57e-05	0.000335	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—GPX1—osteoporosis	1.56e-05	0.000334	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.55e-05	0.000332	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MGLL—osteoporosis	1.54e-05	0.000328	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—RAP1A—osteoporosis	1.53e-05	0.000326	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.51e-05	0.000323	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—MTHFR—osteoporosis	1.44e-05	0.000308	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.39e-05	0.000296	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.32e-05	0.000282	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—IDH2—osteoporosis	1.31e-05	0.000279	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ENO1—osteoporosis	1.23e-05	0.000263	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.23e-05	0.000262	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ENO1—osteoporosis	1.22e-05	0.000261	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PSMA2—osteoporosis	1.22e-05	0.00026	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—PSMA5—osteoporosis	1.22e-05	0.00026	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PSMA2—osteoporosis	1.21e-05	0.000257	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—PSMA5—osteoporosis	1.21e-05	0.000257	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ACP5—osteoporosis	1.19e-05	0.000255	CbGpPWpGaD
Zalcitabine—CYP3A7—Metabolism—POMC—osteoporosis	1.15e-05	0.000246	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—ADCY5—osteoporosis	1.13e-05	0.000242	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—GPX1—osteoporosis	1.13e-05	0.000241	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—TPI1—osteoporosis	1.11e-05	0.000237	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—P4HB—osteoporosis	1.04e-05	0.000223	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—MTHFR—osteoporosis	1.04e-05	0.000223	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GAPDH—osteoporosis	1.02e-05	0.000219	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—RAP1A—osteoporosis	9.98e-06	0.000213	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—CYP19A1—osteoporosis	9.87e-06	0.000211	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—CYP19A1—osteoporosis	9.78e-06	0.000209	CbGpPWpGaD
Zalcitabine—CYP3A5—Metabolism—POMC—osteoporosis	8.34e-06	0.000178	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ENO1—osteoporosis	8.07e-06	0.000172	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—ADCY5—osteoporosis	8.06e-06	0.000172	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—GPX1—osteoporosis	8.03e-06	0.000172	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—ADCY5—osteoporosis	7.99e-06	0.000171	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—GPX1—osteoporosis	7.96e-06	0.00017	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PSMA2—osteoporosis	7.95e-06	0.00017	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—PSMA5—osteoporosis	7.95e-06	0.00017	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—MTHFR—osteoporosis	7.41e-06	0.000158	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—MTHFR—osteoporosis	7.35e-06	0.000157	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.45e-06	0.000138	CbGpPWpGaD
Zalcitabine—CYP2D6—Metabolism—POMC—osteoporosis	5.93e-06	0.000127	CbGpPWpGaD
Zalcitabine—CYP2C9—Metabolism—POMC—osteoporosis	5.88e-06	0.000125	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—ADCY5—osteoporosis	5.27e-06	0.000113	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—GPX1—osteoporosis	5.25e-06	0.000112	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—MTHFR—osteoporosis	4.85e-06	0.000103	CbGpPWpGaD
Zalcitabine—CYP3A4—Metabolism—POMC—osteoporosis	3.88e-06	8.28e-05	CbGpPWpGaD
